Research Methodology – Oncology Clinical Trials Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Oncology Clinical Trials Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the Oncology Clinical Trials Market is developed by integrating key market indicators and macroeconomic variables. These include:
Factors considered while calculating market size and share:
- Existing market size of specific cancer therapeutics and prevalence rate of different cancer types
- The number of active oncology clinical trials globally and their stages
- The cost of clinical trials for cancer drugs
- Market entry and success rates of oncology drugs
- Research and development spending in the oncology sector
- Regional treatment patterns and regulatory environments
- Global population demographics and rising incidence of cancer
- Competitive landscape including key players and their market foothold
- Impact of technological disruptions on the conduct of clinical trials
Key Market Indicators:
- The number of new cancer cases globally
- Number of new drugs approved and in pipeline for cancer
- Demand for personalized medicines and targeted therapy in oncology
- Investments in oncology research and development
- Spendings in the development of novel cancer drugs
- Trends in government funding for cancer research
- Regulatory landscape and policy changes affecting clinical trials
Growth Trends:
- Increased focus on precision medicine and personalized treatment plans
- Rise in the incorporation of AI and digital technology in clinical trials
- Advancements in genomics leading to targeted therapies
- Increase in partnerships between pharmaceutical companies and research institutions
- Growth of immuno-oncology and cell therapy clinical trials
- Emergence of biomarkers in cancer drug development
- Shift towards patient-centric clinical trials improving patient recruitment and retention
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Oncology Clinical Trials Market. Key inputs include:
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the Oncology Clinical Trials Market
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights
Available for purchase with detailed segment data, forecasts, and regional insights.
Get This ReportOur Clients:
